Aviva PLC trimmed its position in shares of Hamilton Lane Inc. (NASDAQ:HLNE – Free Report) by 24.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,109 shares of the company’s stock after selling 1,018 shares during the quarter. Aviva PLC’s holdings in Hamilton Lane were worth $442,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC acquired a new position in Hamilton Lane during the 1st quarter worth approximately $432,772,000. Wellington Management Group LLP lifted its position in shares of Hamilton Lane by 5.5% during the 1st quarter. Wellington Management Group LLP now owns 1,701,963 shares of the company’s stock worth $253,031,000 after purchasing an additional 88,100 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Hamilton Lane by 5.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,368,373 shares of the company’s stock worth $203,437,000 after purchasing an additional 76,107 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in Hamilton Lane by 63.4% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,275,000 shares of the company’s stock valued at $189,555,000 after buying an additional 494,637 shares during the last quarter. Finally, Champlain Investment Partners LLC acquired a new position in Hamilton Lane in the first quarter valued at approximately $112,887,000. Institutional investors and hedge funds own 97.40% of the company’s stock.
Insider Activity
In related news, CEO Juan Delgado-Moreira bought 8,000 shares of the firm’s stock in a transaction on Friday, November 7th. The stock was bought at an average cost of $130.35 per share, for a total transaction of $1,042,800.00. Following the completion of the purchase, the chief executive officer directly owned 1,314,447 shares in the company, valued at approximately $171,338,166.45. The trade was a 0.61% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder River 5 Ltd French sold 150,000 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $146.51, for a total value of $21,976,500.00. Following the sale, the insider owned 330,015 shares in the company, valued at $48,350,497.65. The trade was a 31.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 22.21% of the stock is owned by corporate insiders.
Hamilton Lane Price Performance
Hamilton Lane (NASDAQ:HLNE – Get Free Report) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.46. Hamilton Lane had a return on equity of 29.47% and a net margin of 30.66%.The firm had revenue of $190.88 million during the quarter, compared to the consensus estimate of $171.86 million. As a group, research analysts anticipate that Hamilton Lane Inc. will post 4.97 earnings per share for the current year.
Hamilton Lane Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Friday, December 19th will be paid a dividend of $0.54 per share. The ex-dividend date is Friday, December 19th. This represents a $2.16 annualized dividend and a yield of 1.6%. Hamilton Lane’s payout ratio is presently 39.13%.
Wall Street Analyst Weigh In
A number of analysts have weighed in on the stock. JPMorgan Chase & Co. cut their price objective on shares of Hamilton Lane from $153.00 to $145.00 and set a “neutral” rating on the stock in a report on Wednesday, July 23rd. Keefe, Bruyette & Woods lifted their price target on shares of Hamilton Lane from $150.00 to $158.00 and gave the stock an “outperform” rating in a research note on Thursday, November 6th. Wall Street Zen upgraded shares of Hamilton Lane from a “sell” rating to a “hold” rating in a research note on Sunday, November 9th. BMO Capital Markets assumed coverage on Hamilton Lane in a report on Friday, October 3rd. They set an “outperform” rating and a $150.00 price objective on the stock. Finally, Weiss Ratings cut shares of Hamilton Lane from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Saturday, October 25th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $159.29.
Get Our Latest Research Report on Hamilton Lane
About Hamilton Lane
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Read More
- Five stocks we like better than Hamilton Lane
- Stock Analyst Ratings and Canadian Analyst Ratings
- Are These 3 Oversold Tech Giants Ready to Rebound?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- If You Wait for the Dip, Micron Technology Could Leave You Behind
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Stocks Quietly Powering the AI and Tech Revolution
Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.
